First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
The Journal of Pathology: Clinical Research · 2023-03 · 9 (2) · 100-107
DOI: 10.1002/cjp2.308 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 12.01.2023. Verfasst von Olaf Neumann und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pathologie, Universitätsklinikum Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma harbours druggable genetic lesions including FGFR2 gene fusions. Reliable and accurate detection of these fusions is becoming a critical component of the molecular work‐up, but real‐world data on the performance of fluorescence in situ hybridisation (FISH) and targeted RNA‐based next‐generation sequencing (NGS) are very limited. Bridging this gap, we report results of the first round robin test for FGFR2 fusions in cholangiocarcinoma and contextualise test data with genomic architecture. A cohort of 10 cholangiocarcinoma (4 fusion positive and 6 fusion negative) was tested by the Institute of Pathology, University Hospital Heidelberg, Germany. Data were validated by four academic pathology departments in Germany. Fusion‐positive cases comprised FGFR2 :: BICC1 , FGFR2 :: DBP , FGFR2 :: TRIM8 , and FGFR2 :: ATE1 fusions. In a second step, a round robin test involving 21 academic and non‐academic centres testing with RNA‐based NGS approaches was carried out; five participants performed FISH testing in addition. Thirteen of 16 (81%) centres successfully passed the NGS only and 3 of 5 (60%) centres passed the combined NGS + FISH round robin test. Identified obstacles were bioinformatic pipelines not optimised for the detection of FGFR2 fusions and assays not capable of detecting unknown fusion partners. This study shows the benefit of targeted RNA‐NGS for the detection of FGFR2 gene fusions. Due to the marked heterogeneity of the genomic architecture of these fusions, fusion partner agnostic (i.e. open) methodological approaches that are capable of identifying yet unknown fusion partners are superior. Furthermore, we highlight pitfalls in subsequent bioinformatic analysis and limitations of FISH‐based tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Pathologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.
- Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany.
- Institut für Pathologie, Technische Universität München, Munich, Germany.
- German Cancer Consortium (DKTK), Heidelberg, Germany.
- Qualitätssicherungs-Initiative Pathologie, QuIP GmbH, Berlin, Germany.
- Institut für Pathologie, Ruhr Universität Bochum, Bochum, Germany.
ORCID-Profile: Olaf Neumann, Daniel Kazdal
Zitieren
APA
Neumann, O., Lehmann, U., Bartels, S., Pfarr, N., Albrecht, T., Ilm, K., Christmann, J., Volckmar, A. L., Goldschmid, H., Kirchner, M., Allgäuer, M., Walker, M., Kreipe, H., Tannapfel, A., Weichert, W., Schirmacher, P., Kazdal, D., & Stenzinger, A. (2023). First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma. The Journal of Pathology: Clinical Research, 9(2), 100-107. https://doi.org/10.1002/cjp2.308
Vancouver
Neumann O, Lehmann U, Bartels S, Pfarr N, Albrecht T, Ilm K, et al. First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma. The Journal of Pathology: Clinical Research. 2023;9(2):100-107. doi:10.1002/cjp2.308
BibTeX
@article{Neumann2023,
author = {Neumann, Olaf and Lehmann, Ulrich and Bartels, Stephan and Pfarr, Nicole and Albrecht, Thomas and Ilm, Katharina and Christmann, Jens and Volckmar, Anna-Lena and Goldschmid, Hannah and Kirchner, Martina and Allgäuer, Michael and Walker, Maria and Kreipe, Hans and Tannapfel, Andrea and Weichert, Wilko and Schirmacher, Peter and Kazdal, Daniel and Stenzinger, Albrecht},
title = {First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma},
journal = {The Journal of Pathology: Clinical Research},
year = {2023},
volume = {9},
number = {2},
pages = {100--107},
doi = {10.1002/cjp2.308}
}
EUVIMED